FDA Unveils Plausible Mechanism Pathway to Accelerate Bespoke Gene Editing Therapies
FDA officials Vinay Prasad and Marty Makary have unveiled a new “plausible mechanism pathway” designed to accelerate bespoke gene-editing therapies.
Plausible Mechanism Pathway